How to bid on Actuarial Consultant Services for Nonopioid Drugs with MD Department of Health

What the agency is buying and why it matters

The Maryland Department of Health, specifically Administration, Boards & Commissions, is seeking actuarial consulting services. This work involves reviewing coverage policies for non-opioid drugs, with a focus on prior authorization and step therapy requirements. This is an opportunity for firms to help shape health policy related to pain management and drug access.

Key dates and what happens at the deadline

This Request for Information (RFI) was published on July 22, 2026. The deadline for responses is August 14, 2026, at 4:05 PM ET. All responses must be submitted by this time. Late submissions will not be considered.

Who this opportunity suits

This opportunity is suitable for actuarial consulting firms with expertise in health insurance, pharmaceutical coverage, prior authorization, and step therapy policies. Firms specializing in healthcare economics or drug utilization review would also find this relevant. The category for this solicitation is professional services, specifically actuarial consulting.

How to respond

To access the full solicitation details and respond, you need to use the eMaryland Marketplace Advantage (eMMA) website. You can view the solicitation publicly without an account. However, to download any documents or submit your response, you will need to sign in with a free eMMA supplier account. Ensure you have an account set up well before the deadline.

Practical tips for preparing a competitive response

For an RFI like this, focus on clearly demonstrating your firm's relevant experience and expertise in actuarial analysis related to drug coverage and policy. Highlight any past work with state health departments or similar agencies. Clearly articulate your understanding of prior authorization and step therapy mechanisms and their impact on drug utilization and costs.

Ensure your response is well-organized and directly addresses the information requested in the solicitation. Pay close attention to any specific questions or areas of inquiry outlined by the Department of Health. A concise yet comprehensive response that showcases your firm's capabilities will be most effective.